Office of Diversion Control, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2013

[Federal Register Volume 78, Number 35 (Thursday, February 21, 2013)]
[Notices]
[Page 12102]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03892]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application; Mallinckrodt, LLC

Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 30, 2012, Mallinckrodt, LLC, 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Drug Schedule
Tetrahydrocannabinols (7370) I
Codeine-N-oxide (9053) I
Dihydromorphine (9145) I
Difenoxin (9168) I
Morphine-N-oxide (9307) I
Normorphine (9313) I
Norlevorphanol (9634) I
Amphetamine (1100) II
Methamphetamine (1105) II
Methylphenidate (1724) II
Nabilone (7379) II
4-Anilino-N-phenethyl-4-piperidine (8333) II
Codeine (9050) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Ecgonine (9180) II
Hydrocodone (9193) II
Levorphanol (9220) II
Meperidine (9230) II
Methadone (9250) II
Methadone intermediate (9254) II
Dextropropoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Oripavine (9330) II
Thebaine (9333) II
Opium tincture (9630) II
Opium, powdered (9639) II
Oxymorphone (9652) II
Noroxymorphone (9668) II
Alfentanil (9737) II
Remifentanil (9739) II
Sufentanil (9740) II
Fentanyl (9801) II

The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than April 22, 2013.

Dated: February 8, 2013.

Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2013-03892 Filed 2-20-13; 8:45 am]

BILLING CODE 4410-09-P

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
Got Drugs? Turn in your unused or expired medication for safe disposal here.
Alert! Extortion Scam

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Office of Diversion Control  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539